PATENT CLAIM ANALYSIS

Application Number: 16084357
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["514", "275000"]

Abstract:
The present disclosure relates to solid state forms of Nilotinib fumarate and Nilotinib hydrochloride L-tartaric acid co-crystals, processes for preparation thereof, pharmaceutical compositions thereof, and methods of use thereof.

Claim (Index 3):
The crystalline Form III of Nilotinib fumarate according to  claim 2 , characterized by an XRPD pattern having peaks at 5.5, 7.0, 11.0, 13.4 and 15.8 degrees two theta\u00b10.2 degrees two theta and optionally further characterized by also having one, two, three, four, five, six or seven additional peaks selected from 14.0, 14.9, 16.3, 20.4, 20.5, 20.9 and 25.3 degrees two theta\u00b10.2 degrees two theta.

Metadata:
- Claim Count in Document: 16.0
- Percentile: 97.0
- Lexical Diversity: 1.26923
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13806069', '14538939', '12612943', '13989603', '14772566']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7707234521137145
- 35 USC 102 Novelty (BERT): 0.5512313612326168
- Combined Prediction Score: 0.7487742430256048
- Mean Citation Score: 324.5298160000001
- Max Citation Score: 395.75055
- Similarity Product: 312.07863360899086

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test